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Inactivation of IL11 Signaling Causes
Craniosynostosis, Delayed Tooth Eruption,
and Supernumerary Teeth
Pekka Nieminen,1,* Neil V. Morgan,2 Aime´e L. Fenwick,3 Satu Parmanen,1 Lotta Veistinen,1
Marja L. Mikkola,4 Peter J. van der Spek,5 Andrew Giraud,6 Louise Judd,6 Sirpa Arte,1,7
Louise A. Brueton,2,8 Steven A. Wall,9 Irene M.J. Mathijssen,10 Eamonn R. Maher,2,8
Andrew O.M. Wilkie,3,9 Sven Kreiborg,11,12 and Irma Thesleff4
Craniosynostosis and supernumerary teeth most often occur as isolated developmental anomalies, but they are also separately mani-
fested in several malformation syndromes. Here, we describe a human syndrome featuring craniosynostosis, maxillary hypoplasia,
delayed tooth eruption, and supernumerary teeth. We performed homozygosity mapping in three unrelated consanguineous Pakistani
families and localized the syndrome to a region in chromosome 9. Mutational analysis of candidate genes in the region revealed
that all affected children harbored homozygous missense mutations (c.662C>G [p.Pro221Arg], c.734C>G [p.Ser245Cys], or
c.886C>T [p.Arg296Trp]) in IL11RA (encoding interleukin 11 receptor, alpha) on chromosome 9p13.3. In addition, a homozygous
nonsense mutation, c.475C>T (p.Gln159X), and a homozygous duplication, c.916_924dup (p.Thr306_Ser308dup), were observed in
two north European families. In cell-transfection experiments, the p.Arg296Trp mutation rendered the receptor unable to mediate
the IL11 signal, indicating that the mutation causes loss of IL11RA function. We also observed disturbed cranial growth and suture
activity in the Il11ra null mutant mice, in which reduced size and remodeling of limb bones has been previously described.
We conclude that IL11 signaling is essential for the normal development of craniofacial bones and teeth and that its function is to
restrict suture fusion and tooth number. The results open up the possibility of modulation of IL11 signaling for the treatment of
craniosynostosis.Introduction
The development of craniofacial bones and teeth involves
complex tissue interactions, cell migration, and coordi-
nated growth.1–3 The genetic networks and signaling path-
ways underlying these developmental processes have been
uncovered by the identification of gene mutations that
cause humanmalformations and bymutational and exper-
imental studies in model animals.1,2,4 Genetic craniofacial
malformations range from minor variations in tooth
number to bone-formation defects such as craniosynosto-
sis and severe malformation syndromes that affect
multiple tissues and organs. Craniosynostosis, the prema-
ture closure of cranial sutures, occurs in one of 2500
newborns,2 and although it is sometimes associated with
other congenital defects, most cases of craniosynostosis
appear as isolated traits. Abnormalities in tooth number
constitute the most common craniofacial anomalies; the
prevalence of developmentally missing teeth is 6%–8%
(excluding missing third molars), and that of supernu-
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calvarial bones develop by direct intramembranous ossifi-
cation of the mesenchymal condensations without a prior
cartilaginous template.1 The cells in the center of the
condensations undergo osteoblast differentiation and start
deposition of the mineralizing bone matrix. The bone
grows as a result of continued proliferation and differenti-
ation of the peripheral cells. As the individual bones
approach each other, fibrous sutures form between the
bones and function as joints, allowing further growth of
the skull and face. Growth of intramembranous bones is
also characterized by bone remodeling with localized
apposition and resorption by osteoblasts and osteoclasts,
respectively. The flat calvarial bones grow by bone apposi-
tion at the exocranial side and at the osteogenic fronts at
the sutures. Bone formation continues in the sutures until
they become obliterated and the fusions between adjacent
bones fix their relative positions. The calvarial and facial
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Sutural closure depends on the coordinated regulation
of the proliferation, differentiation, and activity of the
osteoblast precursors at the osteogenic fronts and sutures.
The regulation of bone resorption at the sutures is also
important, and active osteoclasts have been localized in
the growing calvarial bones in mice, especially in the
vicinity of the sutures and on the endocranial surface.7
The morphogenesis of teeth occurs independently of
bone, and the growing tooth germs regulate the remodel-
ing of the surrounding jaw bone. Bone resorption around
the forming teeth is necessary to allow the growth of the
tooth germs and the eruption of teeth into the oral
cavity.8,9
In craniosynostosis, some or several of the sutures
between cranial and facial bones are obliterated prema-
turely, often prenatally. The precocious fusion of calvarial
bones limits the space available for the brain growth and
the skull becomes deformed as a result of compensatory
growth in other sutures. Synostosis of the sutures of
the maxillary complex is most often seen in syndromic
forms of craniosynostosis and has been shown to lead
to maxillary hypoplasia as seen in e.g., Crouzon syndrome
(MIM 123500).10 Mutations in multiple genes have
been identified, most in syndromic forms of craniosynos-
tosis, including activating mutations of fibroblast
growth factor receptors (FGFRs) and loss-of-functionmuta-
tions in TWIST1 (MIM 601622), EFNB1 (ephrin-B1 [MIM
300035]), and EFNA4 (ephrin-A4 [MIM 601380]).11
Involvement of other major signaling pathways, including
hedgehog, is also evident.11 At the cellular level, the muta-
tions affect the border recognition between neural crest-
and mesoderm-derived mesenchymal cells or lead to
accelerated proliferation of the osteoblast precursors or to
their premature differentiation into osteoblasts.1
Supernumerary tooth formation typically involves only
one or a few extra teeth, most commonly a central incisor
located in the maxillary midline, a mesiodens.6 The
occurrence of multiple supernumerary teeth is rare and
is usually associated with syndromes. The molecular
background of supernumerary teeth has been revealed in
a few syndromes. Adenomatous polyposis coli (MIM
175100), a hereditary polypotic cancer syndrome caused
by mutations in APC (MIM 611731), is sometimes associ-
ated with one or more supernumerary teeth or tumor-like
odontomas containing numerous small teeth.12 The APC
gene product normally antagonizes canonical Wnt signal
transduction by b-catenin. The capacity of excess b-catenin
to induce de novo tooth formation has also been shown
in mice.13,14 Cleidocranial dysplasia (MIM 119600) is a
syndrome caused by haploinsufficiency of transcription
factor encoded by RUNX2 (MIM 600211)15,16 and features
multiple supernumerary teeth and delayed or inhibited
eruption of permanent teeth. RUNX2 is required for
bone formation, and its mutations lead to deficient bone
formation and a calvarial phenotype that is opposite to cra-
niosynostosis and features wide cranial sutures and open
fontanelles.1668 The American Journal of Human Genetics 89, 67–81, July 15, 2011In this report, we describe the genetic mapping and
identification of IL11RA (MIM 600939) mutations in an
autosomal-recessive form of craniosynostosis associated
with delayed tooth eruption, maxillary hypoplasia, super-
numerary teeth, and digit abnormalities.Subjects and Methods
Subjects
The parents of families 1–3 originated from Pakistan, and in each
family the parents were first cousins. Families 4 and 5 were of
north European origin and were without known consanguinity.
The four affected siblings of family 1 were patients of the School
of Dentistry, University of Copenhagen, Denmark. The disease
in this family was called as Kreiborg-Pakistani syndrome by
M. Michael Cohen Jr.17 Family 2 consisted of two branches with
a total of five affected individuals, who were ascertained at the
West Midlands Regional Genetics Service, Birmingham, UK. The
probands in families 3 and 4 were included in a cohort of 240
unrelated patients with syndromic or nonsyndromic craniosynos-
tosis (Oxford cohort). The children in family 5 were patients of
Sophia Children’s Hospital, Erasmus MC, The Netherlands.
Patients in families 2 and 5 and in the 240-patient cohort had
been found to be negative for all relevant genetic testing,
including testing of FGFR1 exon 7 (MIM 136350); FGFR2 exons
3, 5, 8, 10, 11, 14, 15, 16, and 17 (MIM 176943); FGFR3 exons 7
and 10 (MIM 134934); and TWIST1 exon 1 (MIM 601622). The
patients and their family members were investigated clinically
and radiographically. Panoramic tomograms for diagnoses of the
dental phenotypes were available for families 1, 3, and 4. Periph-
eral-blood samples were obtained from all family members, and
genomic DNA was isolated via standard methods. All studies
were performed with informed consent of the participants and
under permission of the local institutional ethical committees.
Genetic Mapping
For family1, initial candidate-gene exclusionandfinemappingwas
performed by amplification ofmicrosatellitemarkers (Dynazyme II
DNA polymerase, Finnzymes, Espoo, Finland and appropriate
annealing temperatures and cycle number; 55C–59C and 30–
35 cycles, respectively), and fluorescent detection was performed
in the Molecular Medicine Sequencing Laboratory, Biomedicum
Helsinki. The genome-wide scan was performed at deCODE,
Iceland, with 1113 markers and an average map density of
3.3 cM. Linkage mapping in families 2 and 3 was undertaken in
Birmingham, UK, with the use of genome-wide SNP genotyping
with the Affymetrix Human SNP 5.0 microarray and polymorphic
microsatellite markers. For evaluation of linkage, Simwalk soft-
ware18 was used. The human genome build hg18 (NCBI36) was
used for the marker locations, which were subsequently verified
from build HG19 (GRCh37).
Mutational Analysis
For mutational analysis, exons and flanking intronic regions of
candidate genes were amplified by PCR with Dynazyme Ext
DNA polymerase (Finnzymes) and the use of suitable annealing
temperatures and cycle number (55C–59C and 30–35 cycles,
respectively). The PCR products were purified from free dNTPs
and primers with the ExoSAP-it reagent (USB, Cleveland, OH,
USA) and used as templates in sequencing with the ABI BigDye
Sequencing Kit version 3.1 (Applied Biosystems, Foster City, CA;
for the primers and cycling conditions, see Table S1 available on-
line). The sequencing products were analyzed in the Molecular
Medicine Sequencing Laboratory, Biomedicum, Helsinki. The
results were compared with genomic and cDNA DNA sequences
from GenBank (IL11RA: NT_008413.17 and NM_004512.3) with
bl2exe software.
Whole-genome diploid sequencing in family 5 was performed
by Complete Genomics (Mountain View, CA, USA) as described
before.19 A homozygous recessive disease model was tested on
the father, mother, and two affected children.Bioinformatics
For selection of chromosome 9 candidate genes for mutational
analysis, known interactions with genetic networks important in
skeletal or dental development was studied in the String database
and expression patterns in the GenePaint database. For align-
ments of the IL11RA sequence with other known sequences, we
used BLAST searches and Clustalw. Significance of the observed
changes was estimated with available software, including SIFT,
PolyPhen, SNPs3D, ELM, and NetCGlyc.IL11RA Expression Constructs
To study the effect of the IL11RA mutation on the receptor
function, we inserted the c.886C>T mutation into the human
IL11RA cDNA (corresponding to the GenBank reference sequence
NM_004512.3; kindly provided by Tracy Willson and Lorraine
Robb, Walter and Eliza Hall Institute of Medical Research, Park-
ville, Australia) as template by the overlap extension method.20
Both wild-type and mutant IL11RA (IL11RA/886T) open reading
frames were cloned into pEF1/Myc-His vector (Invitrogen) accord-
ing to standard molecular biology techniques, and resulting
plasmids were verified by sequencing.Cell Culture and IL11 Stimulation Assays
Human 293T cells originating from embryonic kidney
were maintained in Dulbecco’s modified Eagle’s medium (DMEM,
Sigma) supplemented with 10% fetal calf serum, 2 mM glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin, and HeLa cells
(of cervical cancer origin) were maintained in Minimum Essential
Medium (MEM, Sigma) with the same supplements. One day prior
to transfection, 500,000 cells were seeded in 6-well plates. Cells
were transfected with 1 mg of pEF1-IL11RA, pEF1-IL11RA/886T, or
the empty vector with the use of Fugene 6 according to the instruc-
tions of themanufacturer (RocheDiagnosticsGmbH). Twenty-four
hours later, cells were starved overnight in serum-free MEM
medium, 0.2% bovine serum albumin (Sigma), 20 mM HEPES at
pH 7.2, 50 U/ml penicillin, and 100 mg/ml streptomycin. The
following day, medium was removed, and cells were stimulated
for the indicated timeswith 100ng/ml of IL11 (Cell SignalingTech-
nology) in fresh serum-free medium and washed once with PBS,
followed by immediate lysis in Laemmli sample buffer. Proteins
were resolved by 10% SDS-PAGE and transferred onto a Hybond-
C-extra membrane (Amersham), and blots were developed with
the use of enhanced chemiluminesence (SuperSignal West Pico,
Thermo Scientific). Two identical gels were run. In the first, phos-
phorylation of STAT3 was analyzed with pY705-STAT3 antibody
(Cell Signaling Technology, 9145, 1:2000) with the use of horse
radish peroxidase (HRP)-conjugated anti-rabbit antibody (Jackson
Laboratories, 1:5000) as the secondary antibody. After blotting,
the filter was quenched with 3% H2O2 and 0.02% sodium azideThein PBS for 30 min at room temperature, and it was subsequently
blotted with a primary antibody against unphosphorylated
STAT3 (Cell Signaling Technology, 9139, 1:2000) followed by
HRP-conjugated anti-mouse secondary antibody (Jackson Labora-
tories, 1:5000). For verification of the protein levels of the wild-
type and mutant IL11RA, the second gel was blotted either with
an anti-c-myc antibody (Roche Diagnostics GmbH, 11 667 149
001), according tomanufacturer’s instructions,whichwas followed
byHRP-conjugated anti-mouse antibody, or with IL11RA antibody
(R&DSystems,MAB1977,1:1000) andHRP-conjugatedanti-mouse
secondary antibody.
In Situ Hybridization
Heads of staged embryos and postnatal mice of the NMRI strain
were fixed in 4% paraformaldehyde, embedded in paraffin, and
serially sectioned at 7 mm. The expression analysis by in situ
hybridization was carried out according to standard protocols
with the use of 35S-UTP labeling (Amersham). Mouse Il11ra probe
was cloned from E14mouse mandibular cDNA into a pCRII-TOPO
vector (Invitrogen). The probe included the nucleotides 475–1294
of the Il11ra open reading frame (NM_010549.2). The bone
sialoprotein (Bsp) probe was a kind gift from Marian Young,
NIDCR, NIH.
Analysis of Mouse Mutants
The generation of the Il11ra null mutant mice has been described
previously.21 The mice were maintained on a C57BL/6 back-
ground, genotyped by multiplex PCR, and housed in an SPF
facility in microisolater vented cages. Ethical approval was ob-
tained from Murdoch Children’s Research Institute (A583). Heads
of 6-week-old Il11ra null mutant homozygote and heterozygote
mice and wild-type littermates were fixed for 3 days in 95%
ethanol. Skeletal preparations were made by boiling the heads
for 30 min and removing the soft tissues. The microCT analysis
was performed at a 10 mm resolution with the use of a SkyScan
1172 instrument in the BioMater Centre at the University of
Kuopio, Finland.Results
Craniofacial and Dental Findings
Four of the six children in family 1 were affected, whereas
two daughters (IV:1 and IV:5) and the parents had normal
craniofacial features (Figure 1). The parents and healthy
siblings had normal head circumference and jaw relation-
ships and had no history or signs of supernumerary teeth
formation or delayed tooth eruption (Table 1). The oldest
affected child (IV:2) was a girl who was referred at the age
of 11.4 years by an orthodontist because of maxillary
hypoplasia with class III malocclusion and abnormal tooth
eruption. The skull radiographs revealed premature fusion
of all calvarial sutures, increased digital markings, and
a reduced cranial base angle. The other three affected
children were first investigated at comparable ages (IV:3
at 10.8 years, IV:4 at 8.3 years, and IV:6 at 10.6 years).
The two affected boys (IV:3 and IV:4) had complex synos-
tosis of all calvarial sutures. Individual IV:3 underwent
surgery for coronal synostosis at 4 years of age and had a
high, steep forehead and a reduced cranial base angle.American Journal of Human Genetics 89, 67–81, July 15, 2011 69
Figure 1. Pedigrees of the Families
Families 1, 2, and 3were used in the geneticmapping. Squares, females; circles, males; diamonds, sex not indicated; filled, affected; open,
unaffected, double line connecting parents, consanguinity.Individual IV:4 had a strikingly reduced head length and a
brachycephalic and oxycephalic head shape with in-
creased height and a flattened cranial base (Figure 2A).
The youngest girl (IV:6) had fused sagittal and coronal
sutures but patent lambdoid sutures, resulting in a dolicho-
cephalic skull with a protruding forehead and an increased
cranial base angle (Figure 2B). All four affected children
had some degree of midfacial hypoplasia associated with
class III malocclusion. Their permanent teeth had all devel-
oped, but the eruption, especially of canines and premo-
lars, was delayed and several teeth erupted ectopically.
They all also had supernumerary teeth, from 1 to 7 in
number (Tables 1 and 2, Figures 2C and 2D), observed in
the incisor, canine, and premolar regions. These teeth
were delayed for approximately 4 years in their formation
as compared to their counterparts in the permanent denti-
tion, and they were located lingually and occlusally to the
normal permanent teeth.
In family 2, a total of five children with craniosynostosis
had been born to two consanguineous and closely related
couples (Figure 1). The craniosynostosis was diagnosed in
individual IV:1 at the age of 2 years because of severe prop-
tosis and papilloedema (Table 1). Multiple suture synos-
tosis was confirmed radiologically. Four other younger
children in the family were subsequently diagnosed
(IV:4, IV:6, IV:8, and IV:10), and all were surgically treated
with combined craniofacial correction or bicoronal cra-
niectomy. Upon examination after surgery, IV:1 was noted
to have midface hypoplasia, proptosis, a beaked nose, and
brachycephaly; the other affected children had more
subtle clinical findings, with a flat or sloping forehead,
a reduced occipito-frontal circumference (OFC), and mild
proptosis. All affected children had broad great toes with
valgus deformities. Other variable clinical features
included mild syndactyly of the fingers and toes, clinodac-
tyly, prominent helical crura, large upper lateral incisors,70 The American Journal of Human Genetics 89, 67–81, July 15, 2011high palate, and short stature (Table 1). Although one of
the children had a Crouzon-like facies, the family was
not considered typical of any of the previously described
craniosynostosis syndromes.
The only affected individual in family 3, a male (IV:2,
Figure 1), was the second of five siblings. There was no
family history of unusual skull shapes or dental problems.
He presented at the age of 13 months after being noted
during a routine health check as having an unusually
shaped head (Figures 2E and 2F; Table 2). He had had
a high pointed forehead with prominent midline ridging,
and the dura was palpable and bulged through holes that
were eroding the skull posteriorly. There was slight exorbi-
tism and bilateral papilloedema. The remainder of the
examination, including hands and feet, was normal, and
development was appropriate for age. A plain radiograph
of the skull showed marker copper beating, and
a computed tomogram showed a trigonocephalic defor-
mity consistent with metopic synostosis, and closure of
the sagittal, coronal, and lambdoid sutures. He underwent
fronto-orbital advancement and remodeling with lateral
panel extension at the age of 2.0 years. At the age of 5.2
years, he underwent calvarial expansion by forehead
advancement because of the recurrence of raised intracra-
nial pressure. By the age of 12 years, he was noted to
have a compacted palate with dental disarray and persist-
ing deciduous teeth, and he underwent orthodontic assess-
ment. He had evidence of maxillary hypoplasia with class
III malocclusion; all permanent teeth were present, with
palatal eruption of right maxillary premolars and ectopic
eruption of maxillary third molars.
The female proband in family 4 (II:1, Figure 1) was the
first of two siblings born to unrelated parents of white
north European origin. An unusual head shape was noted
at birth. At the age of 13 years, a skull radiograph, obtained
because of dental problems, demonstrated total vault
Table 1. Phenotypic Description of the Affected Family Members in Families 1 and 2
Family 1 Family 2
Patient IV:2 IV:3 IV:4 IV:6 IV:1 IV:4 IV:8 IV:10
Sex female male male female male male male female
First examination 11.4 yr 10.8 yr 8.3 yr 10.6 yr 9 yr 3 yr 8 yr 2 yr
Papilloedema mild mild mild severe mild mild mild
Neurodevelopment normal normal normal normal learning
difficulties
normal normal normal
Increased digital
markings or
copper beating
yes yes yes yes
Metopic synostosis yes yes yes yes yes yes yes yes
Coronal synostosis yes yes yes yes yes yes yes yes
Sagittal synostosis yes yes yes yes yes yes
Lambdoid
synostosis
yes yes yes no no yes
Cranial surgery no 4 yr no no 2.3 yr 2.5 yr 2 yr 1.5 yr
Skull shape brachycephaly
and oxycephaly
brachycephaly flat occiput,
ridged metopic
suture
brachycephaly
Reduced OFC 3rd centile < 3rd centile < 3rd centile < 3rd centile
Forehead high, steep backward slope protruding flat sloping flat flat
Maxillary
hypoplasia
yes (SNA 73) yes (SNA 76) yes (SNA 75) yes (SNA 78) marked mild mild mild
Nose beaked broad,
flat bridge
Cranial base reduced angle
(n-s-ba 125)
reduced angle
(n-s-ba 126.5)
flattened
(n-s-ba 141.5)
increased angle
Palate high narrow
Constricted
nasopharynx
yes yes
Occlusion class III class III incisors
edge-to-edge
incisors
edge-to-edge
Delayed tooth
eruption
yes yes yes yes
Teeth 2 supernum 1 supernum 2 supernum 7 supernum large lateral
incisors
large lateral
incisors
Broad first toes,
hallux valgus
yes yes yes yes
Syndactyly mild 2-3 toe mild 2-3 toe mild 2-3 toe
Clinodactyly yes
Other Crouzon
like features
short stature,
prominent ears
short phalanges,
dysplastic
fingernails
Empty cells indicate unreported or unknown data. Abbreviations are as follows: n-s-ba, nasion-sella-basion angle; OFC, occipito-frontal circumference; SD,
standard deviation unit; SNA, sella-nasion-point A angle.sutural fusion with copper beating (Table 2). At that time,
she was noted to have mild hypertelorism with prominent
eyes, a slightly beaked nose, maxillary hypoplasia, and
marked turricephaly. Her visual acuity was 6/5 in the right
eye and 6/12 in the left eye, and she had an enlarged blind
spot in the left eye. By the age of 19 years, multiple extrac-Thetions of her deciduous teeth had been required to enable
eruption of the permanent teeth. Her brother was not
assessed in detail but was reported to have a similar skull
shape and history of dental problems.
The patients in family 5 are brothers from healthy Dutch
nonconsanguineous parents (Figure 1). The oldest brotherAmerican Journal of Human Genetics 89, 67–81, July 15, 2011 71
Figure 2. Craniosynostosis and Supernu-
merary Teeth
(A) Lateral cephalometric radiograph of
IV:4 in family 1 taken at an age of 10 years,
showing the oxycephalic shape of the
head resulting from complex bilateral
coronal craniosynostosis and maxillary
hypoplasia.
(B) Lateral cephalometric radiograph of
IV:6 in family 1 taken at an age of 10 years,
showing the dolichocephalic shape of the
head resulting from complex craniosynos-
tosis.
(C) Panoramic tomogram of IV:4 in family
1 taken at an age of 9 years, showing two
supernumerary teeth (arrows).
(D) Panoramic tomogram IV:6 in family 1
taken at an age of 10 years, showing seven
supernumerary teeth (arrows).
(E) Craniofacial appearance of the affected
boy IV:2 in family3at theageof13months.
Note mild exorbitism in the absense of
characteristic dysmorphic features.
(F) Superior view of the trigonocephalic
skull of the affected boy IV:2 in family 3
at the age of 13 months.(II:1) was first seen at the age of seven with a ridge over the
sagittal suture, a bony bulge at the vertex, a flattened fore-
head, and hypertelorism (Table 2). Furthermore, his
maxilla was hypoplastic, resulting in exorbitism and mild
obstructive sleep apnea. His X-ray showed synostosis of
all cranial sutures. He was diagnosed with attention deficit
hyperactivity disorder and an IQ of 70–80. The younger
brother (II:2) had a scaphocephalic shape of the head,
with overt frontal bossing. Mild exorbitism and midface
hypoplasia were observed. X-ray proved the sagittal suture
to be closed. In the following years, motor development
turned out to be normal, but a slight delay in speech was
noted.
Genetic Mapping and Mutation Identification
After exclusion of linkage to RUNX2,which is known to be
implicated in bone and tooth development, we performed
genome-wide search in family 1, and we identified several
candidate regions (chromosomes 1, 4, 8, 9, 12, and 14) in
which the affected siblings shared the same homozygous
genotype not present in the unaffected siblings. However,
fine-mapping studies then excluded all regions except
chromosome 9 in which the area of shared homozygosity
extended from D9S265 in 9p21.3 (25,385,580 bp) to
D9S175 in q21.13 (77,947,763 bp) (Figure S1). Multipoint
linkage analysis gave a Simwalk location score of 3.26,
considered as significant evidence for linkage, over the
entire region (Figure 3A).
According to the human genomic sequence, the
region identified in family 1 containsR200 RefSeq genes.
Eleven of these genes were selected for mutational analysis
on the basis of known function and/or expression patterns.
Direct sequencing of the coding regions of these genes
revealed only one previously undocumented sequence
variant that was present in a homozygous state in all four72 The American Journal of Human Genetics 89, 67–81, July 15, 2011affected family members but not in the unaffected
members. This variant, a c.886C>T transition in exon 9 of
IL11RA, resulted in a p.Arg296Trp substitution (Figure 3B).
For family 2, the genome-wide analysis showed that all
five affected children shared a commonhaplotype on chro-
mosome 9 between SNPs rs10967436 (26,608,592 bp) and
rs7044969 (82,078,913 bp), overlapping with the region
of homozygosity in family 1. Genotyping of parents and
siblings with microsatellite markers from chromosome 9
confirmed informative linkage with a maximal location
score of 4.18 (Figure 3A, Figure S2). The chromosome 9
microsatellite markers typed for family 3 showed homozy-
gosity within the candidate regions in families 1 and 2
and a maximal location score of 1.55 (Figure S3, data not
shown).
Subsequent mutational analysis of exons of IL11RA in
samples from families 2 and 3 and from the cohort of cra-
niosynostosis-affected individuals from Oxford revealed
three other mutations that were present in a homozygous
state in the affected family members (Figures 3C–3E).
In the six affected individuals from families 2 and 3, homo-
zygous C>G transversions were detected in exon 8,
at positions 662 (family 2) or 734 (family 3), resulting in
p.Pro221Arg and p.Ser245Cys substitutions, respectively.
In another sample from the Oxford cohort (II:1 in
family 4), a homozygous transition, c.475C>T in exon 6,
encoding the nonsense mutation p.Gln159X, was identi-
fied. None of the unaffected siblings tested in families 2
and 3 was homozygous for these mutations. In addition,
noneof these sequence changeswas observed in400 control
samples of Finnish, other European, or Pakistani (n ¼ 186)
origin, and they are not present in the dbSNP or 1000
Genomes databases. In addition, heterozygous nonsynony-
mous variants, two of which are listed in dbSNP, were
found in different single individuals of the Oxford cohort
Table 2. Phenotypic Description of the Affected Family Members in Families 3–5
Family 3 Family 4 Family 5
Patient IV:2 II:1 II.1 II:2
Sex male female male male
First examination 13 months 13 yr 7 yr 1 yr
Papilloedema moderate mild Yes optic atrophy
Neurodevelopment persistent language delay,
special needs education
normal ADHD slight speech delay
Increased digital markings
or copper beating
yes yes yes
Metopic synostosis yes yes yes no
Coronal synostosis yes yes yes no
Sagittal synostosis yes yes yes yes
Lambdoid synostosis yes yes yes no
Cranial surgery 2 yr, 5.2 yr no
Skull shape trigonocephaly turricephaly,
hypertelorism
ridge over the sagittal
suture, hypertelorism
scaphocephaly,
frontal bossing
Reduced OFC 3rd centile 75 th centile (19 y) ~1SD
Forehead high pointed flat
Maxillary hypoplasia yes yes yes mild
Nose slightly beaked
Cranial base
Palate compacted high-arched
Constricted nasopharynx adenotonsillectomy 8 yr mild
Occlusion class III, dental crowding
Delayed tooth eruption yes yes
Teeth
Broad first toes, hallux valgus no no no no
Syndactyly no no no no
Clinodactyly no no no no
Other Crouzon suggested
Empty cells indicate unreported or unknown data. Abbreviations are as follows: OFC, occipito-frontal circumference; and SD, standard deviation unit.as follows: 128C>T (Ser43Phe; rs76429508), c.130G>A
(p.Val44Met), c.193C>A (p.Pro65Thr; rs11575589),
c.871G>A (p.Val291Ile), c.1090_1104delGAGCAGGTAGC
TGTG (p.Glu364_Val368del).
The three missense mutations encoded within exons 8
and 9 affect amino acids that are located in the second
extracellular fibronectin type domain III (FNIII) (Fig-
ure 3F). This domain of IL11RA, which provides the
predominant contribution for the binding of the IL11
ligand,22 is extremely conserved, and the three amino
acids affected by the mutations are absolutely conserved
in all mammalian IL11RA orthologs (Figure S4). Proline
221 is conserved in all vertebrates, whereas serine 245 is
conservatively replaced by threonine in Xenopus
and arginine 296 by lysine in the nonmammalian ortho-Thelogs (Figure S4). Proline 221 is conserved also in the corre-
sponding positions of two related human cytokine
receptors ciliary neurotrophic factor receptor (CNTFR)
and interleukin 6 receptor alpha (IL6RA), whereas serine
245 is replaced by threonine in human CNTFR and argi-
nine 295 by lysine in CNTFR and by glutamine in IL6R.
Evaluation of these amino acid positions by bioinformatic
software (SIFT, PolyPhen, and SNP3d) suggests that the
observed changes are damaging for the protein function
(Table 3). A similar analysis suggested that two of the
heterozygous changes present in the Oxford cohort as
well as two SNPs reported in the dbSNP database may
also affect protein function (data not shown).
After thewhole-genome sequencing in family 5, a homo-
zygous duplication, c.916_924dup, was detected in theAmerican Journal of Human Genetics 89, 67–81, July 15, 2011 73
Figure 3. Genetic Mapping and Mutational
Analysis
(A) Location score curves from the Simwalk mul-
tipoint analysis of chromosome 9 microsatellite
marker genotypes. red, family 1; blue, family 2.
(B) Chromatograms showing the c.886C>T
(p.Arg296Trp) mutation in exon 9 of IL11RA in
family 1. Upper, unaffected heterozygous father
(III:1); lower, affected homozygous son (IV:4).
(C) Chromatograms from the sequencing of
exon 8 of IL11RA in family 2 showing the
c.662C>G (p.Pro221Arg)mutation in a heterozy-
gous carrier (upper) and homozygous state in one
of the affected individuals (lower panel).
(D) Chromatograms showing the c.734C>G
(p.Ser245Cys) mutation in exon 8 of IL11RA in
family 3. Upper, unaffected control; lower,
affected homozygous son (IV:2).
(E) Chromatograms from sequencings of exon
6 of IL11RA showing the homozygosity in
the proband of family 4 (II:1) for c.475C>T
(p.Gln159X; upper, unaffected control; lower,
II:1 of family 4).
(F) Scheme of the IL11RA protein structure and
location of the mutations. The missense muta-
tions are all located in the second fibronectin-
type domain III (FNIII). Mapping to exons
is shown above and amino acid numbers
below the scheme. sp, signal peptide; Ig-like,
immunoglobulin-like domain; tm, transmem-
brane domain.affected children and was present in a heterozygous state
in the parents. This mutation was not observed in any
other samples, and it is not present in the dbSNP or 1000
Genomes databases. The 9 bp duplication adds a third
Thr-Trp-Ser repeat (p.Thr306_Ser308dup) and affects
a conserved Trp-Ser-NNN-Trp-Ser motif of the class I cyto-74 The American Journal of Human Genetics 89, 67–81, July 15, 2011kine receptors in the C-terminal end of
the second FNIII domain (Figure 3F).22
Bioinformatic tools (ELM and NetCGlyc)
predict that the conserved motif contains
a C-mannosylation signal and that the
duplication strengthens this signal by
adding additional C-mannosylation sites
(Table 3).
The Arg296Trp Mutation Renders the
IL11RA Unable to Mediate the IL11
Signal
Stimulation of IL11RA by IL11 (MIM
147681) triggers activation of the glycopro-
tein gp130 (MIM 600694).23–25 As a conse-
quence of gp130 activation by the IL11/
IL11RA complex, the Janus kinase/signal
transducer and activator of transcription
(JAK/STAT) pathway, predominantly STAT3
(MIM 102582), is stimulated.26,27 We
studied the effect of the c.886C>T
(p.Arg296Trp) mutation on IL11RA func-tion by comparing the ability of the wild-type and mutant
IL11RA to induce STAT3 phosphorylation in transfected
293T cells. The protein levels of wild-type and mutant
IL11RA in transfected 293T cells were comparable
(Figure 4A), and no apparent changes in their intracellular
localization were observed when analyzed by indirect
Table 3. Bioinformatic Analysis of IL11RA Variants
p.Pro221Arg p.Ser245Cys p.Arg296Trp p.Thr306_Ser308dup
Mammalian conservation yes yes yes yes
Vertebrate conservation yes conserved in birds,
Thr in Xenopus
Lys in nonmammals yes
Domain second FNIII second FNIII Second FNIII extracellular
SIFT affects protein
function (0.00)
affects protein
function (0.00)
affects protein
function (0.00)
n.a.
PolyPhen probably damaging probably damaging probably damaging n.a.
PolyPhen PSIC score difference 2.499 1.556 2.255
SNPs3D harmful harmful harmful n.a.
SNPs3D SVM profile ~3.26 ~1.87 ~1.73
ELM no difference no difference no difference stronger mannosylation motif
NetCGlyc no difference no difference no difference additional mannosylation
motifs (1–4)
Second FNIII, second fibronectin type III domain.immunofluorescence (datanot shown). Applicationof IL11
to nontransfected 293T cells or cells transfected with an
empty control vector (pEF1/Myc-His without IL11RA) led
to modest phosphorylation of STAT3 due to activation of
endogenous IL11RA (Figure 4A and data not shown).
However, IL11 induced a much stronger response in cells
transfected with wild-type IL11RA, whereas phosphoryla-
tion of STAT3 in IL11RA/886T-transfected cells did not
exceed the level observed in the control cells (Figure 4A).
Similar data were obtained in HeLa cells, although there
was a higher endogenous activity of IL11RA (Figure 4B).
These results strongly suggest that the Arg296Trpmutation
rendered IL11RA unable to stimulate STAT3-mediated
intracellular signal transduction.
Il11ra Is Expressed in the Craniofacial and Dental
Mesenchyme
The expression of the murine ortholog Il11ra was previ-
ously localized to mesenchymal tissues in mouse embryos,
with prominent expression in the craniofacial mesen-
chyme and later in the dental mesenchyme of incisors.28
We performed a more detailed expression analysis by
in situ hybridization in embryonic and early postnatal
mouse craniofacial tissue sections. In embryonic day 14
(E14) embryos, rather uniform expression was observed
in mesenchymal tissues (data not shown). The expression
in mesenchymal cells was generally increased at E17 and
was particularly strong in the dental papilla of the molar
and incisor tooth germs (Figures 5A and 5D). In addition,
the osteogenic mesenchyme surrounding the forming
mandibular, maxillary, and calvarial bones expressed
Il11ra intensely, but the differentiated osteoblasts associ-
ated with the bone matrix were devoid of transcripts in
all bones (Figures 5B and 5C and data not shown). At post-
natal day 4, intense expression continued in the dental
papilla mesenchyme but was downregulated in the differ-Theentiated odontoblasts (Figure 5G). Expression was strong
in mesenchyme associated with cranial and facial bones,
in particular in all examined sutures, including midpalatal,
frontal, and sagittal sutures (Figures 5E and 5H). Expres-
sion of Il11ra was apparent in the mesenchyme around
the osteogenic fronts of calvarial bones but was downregu-
lated during the terminal differentiation of the osteoblasts
(compare Figures 5E and 5H with Figures 5F and 5I, respec-
tively).
Il11ra Null Mutant Mice Have a Shortened and
Twisted Snout and Synostosis of the Facial Sutures
The phenotype of the Il11ra null mutant mouse has been
analyzed previously. In addition to female infertility as
a consequence of defective uterine response, abnormalities
in bone remodeling were reported in the long bones;29,30
however, the skull phenotype was not reported. We
collected heads from 6-week-old mutant mice and their
heterozygous and wild-type littermates. In skeletal prepa-
rations of the homozygote mutants, we observed several
skulls that were abnormally short. Strikingly, in some
male homozygote null mutant heads, the snouts were
twisted and shorter than in heterozygous or wild-type
littermates (Figures 6A and 6B). Some of the skulls were
subsequently subjected to microCT scanning. We did not
observe synostosis in any of the calvarial sutures. However,
premaxillary sutures in the homozygous mutants showed
signs of suture inactivation (Figures 6C and 6D), especially
on the side where the maxilla was shortest (Figures 6E and
6F). The inactivation of sutures presumably impairs ante-
rio-posterior growth and also leads to the twisting of the
snout. The teeth of the Il11ra null mutants appeared
normal, but several mutants with shortened snouts had
severe dental malocclusion, in that the upper teeth were
posteriorly positioned in relation to the lower teeth
(Figure 6G).American Journal of Human Genetics 89, 67–81, July 15, 2011 75
Figure 4. The p.Arg296Trp Mutation Compromises the Ability
of IL11RA to Induce STAT3 Phosphorylation
293T (A) or HeLa (B) cells transfected with control vector, or with
vectors expressing myc-tagged wild-type IL11RA or mutant
IL11RA (IL11RA/886T) were stimulated for the indicated times
with IL11. Levels of phosphorylated STAT3, total STAT3, and
myc-tagged IL11RA were visualized by immunoblotting. In both
293T and HeLa cells transfection with wild-type IL11RA rendered
cells much more responsive to IL11 while the level of phospho-
STAT3 in IL11RA/886T-transfected cells was comparable to cells
transfected with the control vector.Discussion
Here, we have described a recessively inherited craniofacial
syndrome and identified causative mutations in IL11RA.
IL11RA encodes the interleukin receptor alpha, a well-char-
acterized cell-surface receptor mediating interleukin-11
(IL11) signaling through activation of the coreceptor
gp130. To our knowledge, neither IL11 nor gp130
signaling has previously been linked to congenital malfor-
mations in humans.
The syndrome features synostosis of calvarial bones,
maxillary hypoplasia, delayed and ectopic tooth eruption,
formation of supernumerary teeth, and minor digit abnor-
malities. Craniosynostosis was observed early in infancy
and affected all calvarial sutures, resulting in variable
abnormal skull shapes. The phenotypes suggest that IL11
signaling is important in all sutures and may not have
a predisposing effect for synostosis of specific craniofacial
suture(s). Maxillary hypoplasia is commonly associated
with synostosis of the calvarial bones, particularly in severe
forms of craniosynostosis such as Crouzon and Apert
syndromes (MIM 123500 and 101200, respectively),10 as
a result of precocious ossification of maxillary sutures.
In the affected children in this study, the severity of maxil-
lary hypoplasia varied from moderate to mild and was
less pronounced compared to severe cases of Crouzon76 The American Journal of Human Genetics 89, 67–81, July 15, 2011syndrome, suggesting a later onset of fusion of sutures of
the maxillary complex associated with IL11RA muta-
tions.10 The minor digit abnormalities that were reported
in family 2 are common findings in several craniosynosto-
sis syndromes, but we are not aware of earlier reports in
which craniosynostosis is associated with delayed tooth
eruption and extra tooth formation.
The genome-wide homozygosity-mapping studies in the
three consanguineous families revealed large overlapping
homozygous regions of chromosome 9 in the affected
children. After the mutational analysis of plausible candi-
date genes in family 1, we identified a homozygous point
mutation, p.Arg296Trp, in IL11RA. Examination of this
gene in other families and a large patient cohort led to
the identification of three other homozygous point muta-
tions, p.Pro221Ser, p.Ser245Cys, and p.Gln159X, as well as
of a 3 aa duplication, p.Thr306_Ser308dup. The mutations
were not detected in any of the control samples, even in
a heterozygous state, excluding the possibility that they
are common polymorphisms and collectively providing
evidence that the mutation of IL11RA is causative in these
families.
Currently, the only known ligand for the IL11RA
receptor is interleukin-11. The binding of IL11 to IL11RA
(alpha receptor) leads to the formation of a hexameric
cell-surface complex of two ligands, two alpha receptors,
and two gp130 signaling coreceptors (beta receptors).31
The formation of the signaling complex enables phosphor-
ylation of the intracellular tyrosines of gp130 to trigger
intracellular signal transduction, through either the
JAK/STAT1/3 or the SHP2/MAPK/ERK phosphorylation
cascades.26,27 The three missense mutations described
above affect conserved amino acids in the second extracel-
lular fibronectin type III domain that is mainly responsible
for the interactions of the receptor with the ligand and
the coreceptor gp130.22,32 Cell-transfection experiments
indicated that the p.Arg296Trp mutation renders the
receptor unable to mediate downstream phosphorylation
of STAT3, suggesting that the mutation causes a loss of
gene function. The nonsense mutation p.Gln159X is pre-
dicted to truncate the protein upstream of the ligand-
binding second fibronectin type III domain and/or lead
to nonsense mediated decay of the mRNA, supporting
the conclusion that the phenotypes arise from complete
loss of IL11 signal transduction.
The causative role of impaired IL11 signaling in the cra-
niosynostosis phenotype of our patients was supported by
studies of Il11ra null mutant mice. At 6 weeks of age, these
mice phenocopied the maxillary hypoplasia and class III
malocclusion in our patients. As a likely explanation, signs
of inactivation of premaxillary sutures were evident, espe-
cially on the side of the curvature of the snout. The find-
ings support the idea that the growth disturbance is late
compared to that seen in Crouzon and Apert syndromes.
Skewing of the snout was also observed in the mouse
model for another craniosynostosis syndrome, Muenke
syndrome (MIM 602849), harboring a specific missense
Figure 5. Expression of Il11ra in Devel-
oping Mouse Skull and Teeth
(A–D) In E17 embryos, Il11ra is expressed
in the dental papilla and the surrounding
mesenchyme of the bell stage first molar
(A) and the cap stage second molar (D).
Expression is intense in the calvarial
mesenchyme of the (prospective) sagittal
suture (B). The negative areas in B (arrow-
heads) represent differentiated osteoblasts
and deposited bone matrix as shown
by expression of bone sialoprotein (Bsp)
in C. de, dental epithelium; dp, dental
papilla. Scale bars represent 100 mm.
(E–I) In postnatal day 4 pups Il11ra is ex-
pressed (E) in calvarial mesenchyme and
in the frontal suture (arrow) but excluded
from areas (b) of bone matrix deposition
expressing Bsp (F). In the first molar, depo-
sition of the dental hard tissues is ongoing
and Il11ra is expressed in the dental pulp
(dp) (G). The expression is weaker in the
coronal region of the pulp and absent
from the odontoblasts (arrow) and amelo-
blasts (arrowhead). Il11ra is expressed in
the mesenchyme of the secondary palate
including the palatal suture (arrow) (H).
The negative areas (b) represent differenti-
ated osteoblasts and bone matrix deposi-
tion as shown by expression of Bsp in (I).
Scale bars represent 100 mm in (G) and
50 mm in (E–I).mutation in Fgfr3.33 As in Il11ra mice, the phenotype was
not fully penetrant and synostosis of the calvarial sutures
was observed only rarely.
IL11 is widely expressed in mesenchymal and stromal
cells and has been associated with a variety of biological
functions, including hematopoiesis, placental deciduali-
zation, hippocampal development, and tumorigen-
esis.29; 34–37 Roles for IL11 in the regulation of bone
formation and remodeling have been demonstrated in
several in vitro and in vivo studies.38 Bone remodeling
is a key process in the homeostasis of all bones, and it
is especially important in the growth and development
of the craniofacial bones that form directly from the
mesenchyme without a cartilaginous template and
have to adapt to the growth of the brain and to the
functional needs of mastication.39 Bone remodeling
involves tight spatiotemporal control of bone apposition
by the osteoblasts derived from osteogenic mesenchyme
and of bone resorption by the osteoclasts of hematopoi-
etic origin, and it is controlled by systemic and local
factors and by complex crosstalk between the two cell
types.40,41
IL11 supports the differentiation of osteoblasts from
cultured bone marrow cells, mesenchymal cell lines, and
periodontal ligament cells.42–44 In adult transgenic mice,
overexpression of Il11 in bone leads to increased apposi-
tion and preservation of bone with apparently cell-auton-
omous activation of osteoblast differentiation.43 IL11 acts
synergistically with bone morphogenetic proteins (BMPs)Thein promoting bone apposition and target gene activity in
osteoblastic cells in vitro and during bone repair.43,45,46
Furthermore, because Il11 expression is upregulated by
mechanical loading in osteoblasts, it may be one of the
molecular mediators of functional regulation of bone
growth and remodeling.47
Although there is substantial evidence that IL11 signal-
ing supports osteoblast differentiation and function,
it also has a significant role in osteoclast differentiation.
The previous studies on the long-bone phenotype of
Il11ra-deficient mice indicated that blocking IL11
signaling decreases both bone formation and resorption,
and the trabecular bone volume was increased while the
bone dimensions and cortical bone thickness were slightly
reduced.30 Interestingly, when osteoblast or osteoclast
precursors from these mice were cultured, the osteoblasts
differentiated normally but osteoclast differentiation was
impaired in a cell-autonomous fashion, suggesting that
the primary defect resides in osteoclast differentiation.30
This finding is in line with earlier studies showing that
IL11 signaling supports osteoclast differentiation indi-
rectly via TNFSF11 (earlier called RANKL, MIM 602642)
induction in osteoblasts48–51 and also by direct TNFSF11-
independent action on osteoclast precursors.52
In our in situ hybridization analysis of Il11ra expression
in the forming craniofacial bones of embryonic and post-
natal mice, we observed intense expression in the mesen-
chyme surrounding the bones while the differentiated
Bsp-positive osteoblasts in the sutures and developingAmerican Journal of Human Genetics 89, 67–81, July 15, 2011 77
Figure 6. Craniofacial Phenotype in the Il11ra Null Mutant
Mouse
(A and B) MicroCT image of anterior part of skull of a wild-type
mouse (A) and a homozygous Il11ra null mutant littermate (B).
The snout of themutantmouse is significantly shorter and twisted
to the left.
(C and D) Inferior view of the same skulls as in (A) and (B). The
premaxillary suture of the mutant (D) shows remarkably weaker
interdigitation (arrows) than that of the wild-type littermate (C).
(E and F) Lateral view of premaxillary sutures of the mutant
mouse. The suture on the left side (F), i.e., ipsilateral to the
direction of twisting of the snout, is straight and has smooth
edges, as compared to the suture with serrated edges on the right
side (E).
(G) Severe dental malocclusion in an Il11ra null mutant mouse.
The maxillary (upper) teeth are in an abnormal posterior position.jaw bones were devoid of Il11ra transcripts. These findings
are in line with the observation from a microarray screen
indicating that the expression of IL11RA was higher in
nonfused than in fused sutures.53 Thus, the expression
analyses in craniofacial bones suggest that IL11 signaling
does not affect the secretory function of osteoblasts but
may affect osteoblast precursors and osteoclasts.
So far, defects in the regulation of proliferation and
differentiation of the osteoblast precursors have been
shown to contribute to craniosynostosis in the mouse
models of the human syndromes caused by mutations
in FGF receptors, MSX2 (MIM 123101), TWIST, and
EFNB1.11 Our observations of premaxillary suture inactiva-
tion in the Il11ra null mutant mice are strikingly similar to
those in mice with mutated Fgfrs,33,54 suggesting that78 The American Journal of Human Genetics 89, 67–81, July 15, 2011mutations in IL11RA have effects on suture maintenance
similar to those in observed FGFRs. However, though not
previously demonstrated, it is conceivable that failure of
bone resorption may also lead to precocious synostosis of
craniofacial bones. Active osteoclasts are present in the
developing calvarial sutures of pre- and postnatal mice.7
Our findings show that IL11 signaling is critical for the
maintenance of suture patency. The available data suggest
that the craniosynostosis phenotype seen in IL11RA-defi-
cient humans and mice results from a failure to regulate
bone remodeling, i.e., from an imbalance between bone
apposition and resorption at the osteogenic fronts in the
sutures. Given that the inactivation of Il11ra in mice
appears to cause a cell-autonomous inhibition of osteoclast
differentiation, it is possible that the synostoses observed
in human patients and the null mutant mice result from
a primary defect in bone resorption. Interestingly, ephrin
signaling has recently been associated with communica-
tion between osteoclasts and osteoblasts, suggesting that
defects in bone resorption may contribute to craniosynos-
tosis caused by mutations in ephrins.55
The suggestion that the mutations in IL11RA caused
impaired bone resorption is further supported by the
delayed and ectopic tooth eruption in our patients. Local-
ized resorption of the jaw bone by osteoclasts is a prerequi-
site for tooth eruption,9 and indeed, increased expression
of Il11 has been associated with accelerated tooth eruption
and increased bone resorption in Mcp (monocytic chemo-
attractant protein) null mutant mice.56
The association between IL11RA mutation and super-
numerary teeth provides the first evidence that the IL11-
RA-gp130pathway regulates patterning of any organ. The
reported large incisors in family 2 may also present an
effect of the IL11RA mutation on tooth development, but
unfortunately we were not able to assess the dental pheno-
type in this family in detail. All the tooth types that are
normally replaced once (namely incisors, canines, and
premolars) were represented among the supernumerary
teeth. They were, on average, 4 years delayed in develop-
ment compared to the permanent teeth and localized on
the lingual side of the jaw and occlusally to the permanent
teeth. Thus, their developmental timing and location are
strikingly similar to the supernumerary tooth phenotype
associated with cleidocranial dysplasia, caused by haploin-
sufficiency of RUNX2.15,16 It is possible to consider the
supernumerary teeth in these syndromes as a representa-
tion of a third dentition,15 and thus the mutations in
RUNX2 and IL11RA appear to unlock the capacity for
multiple or continuous tooth replacements as seen in
fish and reptiles. The absence of supernumerary teeth in
the Il11ra and Runx2 null mutants57 is likely explained
by an essential lack of capacity for tooth replacement
in mice given that they only develop one set of teeth.
The very similar phenotypes of supernumerary tooth
formation resulting from cleidocranial dysplasia and
IL11RA mutation, as well as the coexpression of Runx2
and Il11ra in the craniofacial and dental mesenchyme,57
raise the possibility that the genes function in the same
genetic pathway that potentially interacts with Wnt
signaling.13,14
It is noteworthy that despite the similarity of the super-
numerary tooth phenotype in the syndrome described
here and in cleidocranial dysplasia, the bone phenotypes
are directly opposite, because cleidocranial dysplasia
features hypoplasia of cranial bones, with wide sutures
and open fontanelles. In the case of Runx2 there is
evidence that the gene regulates tooth development inde-
pendently of its effects on bone development.57,58 Thus, it
is possible that the effects of the IL11RA and RUNX2 and
their proposed interactions depend on the context.
In conclusion, we have shown that IL11 receptor signal-
ing is needed to prevent premature craniofacial sutural
fusion in man and mouse, to limit the formation of
replacement teeth to the normal single set of secondary
teeth in humans, and to allow normal tooth eruption. We
suggest that the pathogenesis of delayed and ectopic tooth
eruption involves impaired resorption and remodeling
of bone due to the lack of IL11 signaling in the bone-
resorbing osteoclasts and that this may also contribute to
craniosynostosis. Furthermore, because IL11 is a negative
regulator of suture closure, it is tempting to speculate that
IL11 or other components of gp130 signaling could be
applied therapeutically to prevent suture recurrence of
craniosynostosis after surgery. The mutation in IL11RA is
one of the few identified recessive causes of craniosynostosis
inman, and itwas identifiedbecause of the consanguinity in
the affected families who displayed variable phenotypic
features associated with craniosynostosis. Although IL11RA
craniosynostosis syndrome appears to be infrequent, it is
possible that mutations in other components of the
IL11/gp130 signaling pathway may also contribute both to
craniosynostosis and to supernumerary teeth.Supplemental Data
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